Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue $ 3,465 $ 2,211 $ 6,032 $ 4,121
Cost of revenue 1,824 919 3,182 1,594
Gross profit 1,641 1,292 2,850 2,527
Operating expenses:        
Sales and marketing 1,841 1,787 3,470 3,580
Research and development 920 709 1,919 1,312
General and administrative 2,109 2,144 4,927 4,122
Total operating expenses 4,870 4,640 10,316 9,014
Loss from operations (3,229) (3,348) (7,466) (6,487)
Other income (expense), net:        
Interest expense (29) (27) (56) (53)
Gain on revaluation of warrant liabilities 999 875 899 886
Other expense, net (1) (3) (3) (16)
Total other income (expense), net 251 2,075 (132) 1,544
Net loss (2,978) (1,273) (7,598) (4,943)
Other comprehensive income (loss) 639 (125) 851 340
Comprehensive loss $ (2,339) $ (1,398) $ (6,747) $ (4,603)
Net (loss) income per share applicable to common shareholders, basic (in dollars per share) $ (0.23) $ (0.10) $ (0.59) $ (0.42)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.23) $ (0.11) $ (0.59) $ (0.44)
Weighted average number of shares outstanding, basic (in shares) 12,884 12,655 12,807 11,709
Weighted average number of shares outstanding, diluted (in shares) 12,884 12,737 12,807 11,839
Foreign Currency Transaction Gain (Loss), before Tax $ (718) $ 131 $ (972) $ (372)
Gain on forgiveness of note payable $ 0 $ 1,099 $ 0 $ 1,099